Skip to content
On this page:OverviewPublicationsResearchersInstitutionsOpen access
PICO Portalanswers from OpenAlex

Alzheimer's Association of Israel

InstitutionResearch output, impact & collaborations

Alzheimer's Association of Israel is a institution indexed in PICO Portal from OpenAlex.

What is known about Alzheimer's Association of Israel?

PICO Portalrecord summary

Alzheimer's Association of Israel is a research organisation in Ramat Gan, IL. OpenAlex records 1,251 works and 57,691 citations for it. 505 researchers list it as their most recent affiliation.

How many works does Alzheimer's Association of Israel have?

PICO Portalindexed works

Alzheimer's Association of Israel has 1,251 works in the PICO Portal index. The count is the OpenAlex total, not the number of papers listed on this page.

How many citations does Alzheimer's Association of Israel have?

PICO Portalcitation count

Alzheimer's Association of Israel has 57,691 citations in the OpenAlex counts PICO Portal stores.

How many researchers are at Alzheimer's Association of Israel?

PICO Portalresearcher count

Alzheimer's Association of Israel has 505 researchers in the PICO Portal index.

What is the average h-index at Alzheimer's Association of Israel?

PICO Portalavg h-index

Alzheimer's Association of Israel has an average h-index of 56 in OpenAlex.

What is the ROR of Alzheimer's Association of Israel?

PICO Portalror

The ROR for Alzheimer's Association of Israel is on the source record.

What is the OpenAlex record for Alzheimer's Association of Israel?

PICO Portalopenalex

The OpenAlex for Alzheimer's Association of Israel is on the source record.

Who are the most-cited researchers behind Alzheimer's Association of Israel?

PICO Portaltop researchers by citations
1
Ofri Mosenzon · Diabetes Treatment and Management
268 works27,236 citations

What are the most-cited papers on Alzheimer's Association of Israel?

PICO Portalmost cited works
Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes
Stephen D. Wiviott, Itamar Raz, Marc P. Bonaca, Ofri Mosenzon, Eri Kato, Avivit Cahn, Michael G. Silverman, Thomas A. Zelniker, Julia Kuder, Sabina A. Murphy, Deepak L. Bhatt, Lawrence A. Leiter, Darren K. McGuire, John Wilding, Christian T. Ruff, Ingrid Gause‐Nilsson, Martin Fredriksson, Peter A. Johansson, Anna-Maria Langkilde, Marc S. Sabatine
New England Journal of Medicine. 20186,387 CitationsOPEN ACCESS
Saxagliptin and Cardiovascular Outcomes in Patients with Type 2 Diabetes Mellitus
Benjamin M. Scirica, Deepak L. Bhatt, Eugene Braunwald, Philippe Gabríel Steg, Jaime A. Davidson, Boaz Hirshberg, Peter Öhman, Robert Frederich, Stephen D. Wiviott, Elaine Hoffman, Matthew A. Cavender, Jacob A. Udell, Nihar R. Desai, Ofri Mosenzon, Darren K. McGuire, Kausik K. Ray, Lawrence A. Leiter, Itamar Raz
New England Journal of Medicine. 20133,486 CitationsOPEN ACCESS
SGLT2 inhibitors for primary and secondary prevention of cardiovascular and renal outcomes in type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials
Thomas A. Zelniker, Stephen D. Wiviott, Itamar Raz, KyungAh Im, Erica L. Goodrich, Marc P. Bonaca, Ofri Mosenzon, Eri Kato, Avivit Cahn, Remo H.M. Furtado, Deepak L. Bhatt, Lawrence A. Leiter, Darren K. McGuire, John Wilding, Marc S. Sabatine
The Lancet. 20182,848 Citations
Oral Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes
Mansoor Husain, Andreas L. Birkenfeld, Morten Donsmark, Kathleen Dungan, Freddy G. Eliaschewitz, Denise Reis Franco, Ole Kleist Jeppesen, Ildiko Lingvay, Ofri Mosenzon, Sue D. Pedersen, Cees J. Tack, Mette S. Thomsen, Tina Vilsbøll, Mark Warren, Stephen C. Bain
New England Journal of Medicine. 20191,969 CitationsOPEN ACCESS
Efficacy and safety of semaglutide compared with liraglutide and placebo for weight loss in patients with obesity: a randomised, double-blind, placebo and active controlled, dose-ranging, phase 2 trial
Patrick M. O’Neil, Andreas L. Birkenfeld, Barbara McGowan, Ofri Mosenzon, Sue D. Pedersen, Sean Wharton, Charlotte Giwercman Carson, Cecilie H. Jepsen, Maria Kabisch, John Wilding
The Lancet. 2018813 Citations

How much of the research on Alzheimer's Association of Israel is open access?

PICO Portalopen access share
58%OPEN ACCESS
Gold
0%
Green
0%
Hybrid
0%
Bronze
58%
Closed
42%

Related on PICO Portal

470M+ articles · 14-day free trial